Results 171 to 180 of about 48,009 (234)

Acute severe hypocalcaemia after initiation of a selective RET-inhibitor in medullary thyroid cancer. [PDF]

Endocr Oncol
Cheng L, Ghaznavi SK, Stevens J, Hoy S, Wong KH, Malik T, Newbold K, Morganstein D.   +7 more
europepmc   +1 more source

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study [PDF]

, 2018
et al,, Gambacorti-Passerini, Carlo, Van Tine, Brian A   +2 more
core   +1 more source

Anterior mediastinal tracheostomy - a salvage procedure for tracheal necrosis after thyroidectomy for medullary thyroid cancer: a case-report. [PDF]

World J Surg Oncol
Hemead H, Patel AJ, Jesani H, Kumar S, Ahmed I, Parmar S, Warner R, Sharma N, Kalkat MS.   +8 more
europepmc   +1 more source

Diagnosis of Bone Metastasis due to Medullary Thyroid Cancer With ^99mTc- (V) DMSA SPECT Imaging. [PDF]

Clin Case Rep
Gharepapagh E, Houshyar J, Mamaghani FF, Karbasi M, Rezaei S.   +4 more
europepmc   +1 more source

A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer. [PDF]

BMC Cancer
Alqahtani T, Alsubait A, Aloumi M, Alamer A, Alomari G, Alwassil OI, Obaidullah AJ, Alghamdi SS.   +7 more
europepmc   +1 more source

Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin. [PDF]

Front Endocrinol (Lausanne)
Wang B, Huang J, Chen L.
europepmc   +1 more source

Tumor Volume Doubling Time of Less Than 1 Year Is Associated With a Higher Risk of Death From Medullary Thyroid Cancer.

J Clin Endocrinol Metab
Behairy N, Leonardi AJ, Gubbi S, Kumari S, Pascoal M, Bharadwaj A, Dorgham A, Wright EC, Abijo T, Uttarkar Vikram CN, Veeraraghavan P, Cochran C, Akshintala S, Glod J, Klubo-Gwiezdzinska J.   +14 more
europepmc   +1 more source